Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...

Granules India receives FDA approval for generic ADHD drug, expanding portfolio and reinforcing presence in treatment space.

The following is a summary of “Pediatric Attention-Deficit/Hypearativity Disorder and Disruptive Mood Dysregulation Disorder: ...

Prescription drugs for ADHD can have side effects for your skin and hair. Here’s what a dermatologist (who’s also a ...

ROCKVILLE, Md. - Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a biopharmaceutical company specializing in CNS diseases with an impressive 89% gross profit margin, has announced the FDA approval of a ...

Adderall shortages have prompted doctors to switch kids with attention-deficit/hyperactivity disorder (ADHD) to other ...

Many with ADHD report that medication — typically a stimulant but treatment can also include non-stimulants and ...